ABSTRACT
INTRODUCTION
Clostridium difficile infection (CDI) is a frequent cause of healthcare-associated diarrhea. It is associated with an infectionrelated mortality of 5%, and has an all-cause mortality of 15% -20%. 1, 2 The epidemiology of CDI has changed since the emergence of the B1/NAP1/027 strain in the early 2000s. This ribotype has been responsible for an increase in incidence and severity of CDI. 3 Current guidelines for the treatment of CDI recommend metronidazole for mild-to-moderate infection and vancomycin for severe infection. 4 A first recurrence is usually treated with vancomycin, and subsequent recurrences are treated with a tapered regimen of vancomycin, fidaxomicin or fecal microbiota transplantation (FMT). 4, 5 Fidaxomicin and FMT both appear to lead to fewer recurrences. 6, 7 Early identification of patients at risk of a complicated course or death could help clinicians inform patients and might help doctors guide antibiotic treatment. Several scoring systems to predict a complicated course of CDI have been developed (Table   1) . [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] However, none has gained widespread clinical acceptance due to lack of external validation, the retrospective study design, or the limited numbers of patients on which they are based. 20 To our knowledge, to date, only one study has been externally validated. 21 In four studies, internal validations were performed. 8, 9, 17, 19 Between May 2013 and July 2014, the frequency of CDI cases increased above our usual endemic levels due to an outbreak of C. difficile ribotype 027. 22 The aims of the current study were to test published prediction models for complicated CDI for clinical use and to provide external validation for existing prediction models.
METHODS

Source of data
We searched PubMed and Embase for studies on prediction tools for a severe or complicated course of CDI up to February 2016 (Appendix A). We selected studies that
(1) predicted at least one relevant outcome (ie, severity, complications, mortality) and (2) developed a prediction model or risk score. Only completed studies were included.
Prediction tools that used a selected patient group (eg, only ICU patients), included nonquantitative parameters (eg, Horn's index, mental status), or parameters that
were not available at the day of diagnosis in our cohort (eg, radiological findings or albumin concentration) were excluded. 8 and by Na et al. 9 In addition, we collected data on all cause 30-day mortality for validation of the prediction score by Welfare et al. 17 Whether the course of CDI was considered complicated was assessed by the study physician after chart review.
Patient validation cohort and data collection
Missing Data
Most predictors had <1% missing data. However, 7% -10% of values were missing for blood pressure on the day of diagnosis, white blood count, and serum creatinine level.
When both diastolic and systolic blood pressure measurements were missing, we presumed that the patients had no hypotension on the day of diagnosis. To account for missing data on white blood count (N = 14) and serum creatinine level (N = 10), values were imputed using multiple imputation (10 imputed datasets). 26 The predictors in the selected studies, the outcome variable, and 5 additional variables (sex, Charlson comorbidity index 23 , CDI due to ribotype 027, temperature ≥38.5°C, ward of CDI diagnosis) were included in the imputation procedure. 
Statistical Analysis
Using the same multivariable models as used in the original studies, demographic characteristics and risk factors used in the prediction models were compared between patients with and without the outcome to give insight in the association between these predictors and the outcome in our validation cohort. These procedures were conducted using standard logistic regression. Risk scores were calculated for each patient by adding the allocated points for each variable according to the respective prediction model. To quantify how close predictions are to the actual outcome (calibration), we plotted the observed number of complicated cases against the predicted number of complicated CDI courses in the simplified risk categories provided by the original studies. The ability of the prediction models to discriminate between those with and without a complicated CDI course was assessed by calculating the area under the receiver operating characteristic (ROC) curve (AUC), which ranges from no discrimination (0.5) to perfect discrimination (1.0). 27 Because all prediction models were developed in an endemic setting, in a second step, we reexamined calibration and discrimination within the group of patients who had been diagnosed with CDI due to endemic strains (ie, strains that had never caused outbreaks in our hospital). SPSS version 22 software (IBM, Armonk, NY) was used for statistical analysis.
RESULTS
Selection of Prediction Models
We identified 12 papers presenting a prediction model for a complicated course of CDI (Table 1) 8 -18 , of which eight studies were excluded because they included a selected patient group 18 , used nonquantitative parameters (eg, altered mental status, Horn's index) [10] [11] [12] , or used variables that were not available in our cohort on the day of CDI diagnosis (eg, serum albumin, radiological findings). [12] [13] [14] [15] [16] 19 Age, white blood count, and albumin level were used in the prediction model in >50% of the studies. All other 24 predictors were used in only 10% or 20% of models. In this study, we sought to validate three prediction models from three different studies. Study and patient characteristics of the 3 derivation studies, and of our validation cohort are shown in 
Patient Characteristics of the Validation Cohort
Patient characteristics are shown in Table 2 . In total, 148 CDI patients were included in the validation set, of which 78 patients diagnosed with CDI due to the outbreak strain ribotype 027, and 70 patients with CDI due to other ribotypes (Table 3 ). In general, no differences were observed between the derivation study cohorts of A complicated course due to CDI was observed in 31 patients (21%), and 23 patients (16%) died within 30 days after CDI diagnosis; death was CDI related in 13 of these cases. Because of severe pseudomembranous colitis, one patient with CDI underwent a colectomy. Overall, 20 patients were admitted to the ICU after CDI diagnosis; 13 of these cases were related to CDI.
Model Performance
The association between predictors and a complicated course of CDI 8, 9 or 30-day mortality 17 in the validation cohort was analyzed by multivariable logistic regression using the same multivariable models as the original studies (Table 4) .
Prediction model by Hensgens et al. 8 In the validation cohort, the median score using the prediction tool developed by 
27
Prediction model by Na et al. 9 The median score, using the prediction tool developed by Na et al. in the validation cohort, was 1 (range, 1 -3). No statistically significant association was identified in a multivariable model between the predictors by Na et al. and a complicated course of CDI in our cohort. We compared the observed and predicted outcomes for the different risk groups defined by the prediction rule ( Figure 1 and Appendix C).
Discrimination of the prediction model failed (AUC 0.53; 95% CI 0.42-0.65; Figure   2 .1). 27 Analysis restricted to patients with CDI due to non-outbreak strains, also showed very poor discrimination (AUC 0.54; 95% CI 0.39-0.70; Figure 2 .2). 8 and by Na et al. 9 Observed versus predicted complicated course per simplified risk group following their prediction scores.
Prediction model by Welfare et al.
17
In the validation cohort, the median score using the prediction model of Welfare et al.
was 3 (range, 0-6). Only age ≥80 years was significantly associated with 30-day mortality. We were not able to compare the observed outcome in our cohort with the predicted outcome defined by the prediction rule due to lack of data in the original 
DISCUSSION
In this study, we validated three prediction models, all designed to identify patients at risk for a complicated course of CDI or death within 30 days after diagnosis, using a validation cohort in which approximately half of patients were part of a CDI outbreak caused by ribotype 027. When applied to our total cohort (outbreak strain and nonoutbreak strains), all three prediction models performed poorly. However, because the prediction tools were derived in endemic settings and because infection with C.
difficile ribotype 027 has been associated with more severe outcomes [28] [29] [30] [31] , we also tested the prediction models on our cohort excluding patients infected with the outbreak strain C. difficile ribotype 027. In this restricted analysis, the prediction model developed by Hensgens et al. performed much better, with an AUC of nearly 0.
8. This refinement provided strength to our study, showing that a prediction rule can only be applied in a cohort that is comparable with the derivation cohort.
The recent guideline of the Infectious Diseases Society of America (IDSA) recommends that age, peak leucocyte count, and peak serum creatinine level could be considered as indicators of a complicated course of CDI when treatment is started. 4 Na et al. used these three variables in their prediction model. However, our study findings did not support their prediction tool, which seems counterintuitive. This difference may be due to the dichotomized scoring system or to the chosen cutoff points of the different variables. In addition, it has been suggested that measurements of leucocyte count and serum creatinine level at different times around the day of CDI diagnosis lead to different severity classifications in many cases. 32 Na et al. used a time interval of seven days for the measurement of peak leucocyte count and serum creatinine level, which could have contributed to the poor performance of their prediction rule. The prediction model developed by Hensgens et al. was constructed using adequate methodology: the predictors were selected using backward selection, and bootstrapping techniques were used to adjust for overfitting. 33 Additionally, this scoring system was based on clinical parameters that are available after the completion of medical history and physical examination, which enables the attending physician to use it for treatment guidance. 8 clinical diagnoses were obtained from medical charts, which differs from the derivation study in which administration codes were used. These differences are a limitation of our study, and they could have influenced the performance of their prediction tool in our cohort. Unfortunately, the number of patients in the older age category in our validation cohort was too small to allow a validation in this subset. A second limitation of our study was the difference between the validation and derivation cohorts: the derivation cohorts consisted of patients diagnosed with CDI in an endemic setting, whereas our validation cohort consisted of all patients diagnosed with CDI (due to the outbreak strain, and due to other strains) during an outbreak of C. difficile ribotype 027. The number of patients who developed a complicated course of CDI was significantly higher among patients diagnosed with CDI due to ribotype 027 than among non-027 CDI patients. Third, we used existing patient data files; therefore, some data were missing. We found 12 studies on prediction rules for a complicated course of CDI. Due to missing data for several variables per prediction tool, we were not able to validate all 12 different prediction tools. However, as shown in Table 1 , except for number of leucocytes, serum albumin (which is not measured routinely in our hospital), and age, there was much heterogeneity in the variables used in the various scores. In addition, inclusion of nonquantitative parameters and parameters that are not routinely available at time of diagnosis limits the use of prediction tools in clinical practice. Importantly, a recent systematic review showed that most prediction tools presented several methodological limitations and weak validities, which lead to suboptimal quality and debatable utility in clinical settings. 20, 34 Fourth, the relatively small sample size affected the precision of the estimates. Missing data were imputed using multiple imputation; when data on blood pressure measurements were missing, we made the assumption that patients had no hypotension on the day of diagnosis. Although we feel that these corrections for missing data were accurate, this factor could have influenced the results. cohort. These differences made it difficult to fully assess similarities between the validation cohort and the derivation cohorts.
In conclusion, our study shows that a prediction rule can only be used in a cohort comparable with the derivation cohort. The performance of all three validated prediction models was disappointing in a combined epidemic/endemic setting, and can therefore not be used during a CDI outbreak to predict a complicated course of CDI. The prediction model by Hensgens et al. performed relatively well, however, to identify patients with CDI at risk for a complicated course when the validation cohort was restricted to patients with CDI due to non-outbreak strains. This prediction model can therefore be used in an endemic setting to identify patients at risk for CDI complications, aiding clinicians in deciding which patients to monitor closely for CDIrelated complications. Future clinical trials should be directed at determining whether early treatment and choice of treatment directed by the severity score improves patient outcomes.
